跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,489 条关于
“Risperidone LAI”
全部
4,489
临床试验
1,886
药物
333
机构
180
资讯
2,090
去年
Olanzapine LAI Shows Promise in Schizophrenia Treatment with Improved Safety Profile
去年
Teva's Olanzapine LAI Shows Positive Phase 3 Results for Schizophrenia
6个月前
Medincell Raises Capital to Advance Long-Acting Injectable Platform and Expand Partnerships
去年
Teva and MedinCell's Long-Acting Risperidone Injection Expands Global Reach with Canadian Approval
去年
Teva Unveils $5 Billion Growth Strategy with Five Potential Blockbuster Drugs in Late-Stage Pipeline
17天前
Medincell Appoints Edna Venneker, MD, as Chief Medical Officer
去年
Weekly Oral Risperidone Shows Promise for Schizophrenia Treatment in Phase 3 Trial
11个月前
Major UK Study Reveals Risperidone Increases Stroke Risk Across All Dementia Patient Groups
12个月前
Teva's Olanzapine LAI Shows No PDSS Events in 56-Week Phase 3 Trial, Paving Way for First Long-Acting Olanzapine Treatment
去年
Teva's TEV-'749 Shows Promise in Improving Social Functioning in Schizophrenia Patients
第 1 页,共 209 页
上一页
下一页